Facts (185)
Data Freshness
Ageing
Last update: 161d ago · Avg age: 485d
Confidence Tiers:
Primary Source — cross-referenced government/corporate filings
Pending Review — sourced but not independently verified
AI Inference — analytical hypothesis from cross-referencing
✓ Verified Findings (104)
Independently re-checked: a second model read the source artifact and confirmed it supports the extracted claim.
⚠ flagged by Gemini
Partially Corroboratedw·40
Crescendo Equity Partners initiated the sale of HPSP during a period when it was simultaneously raising Fund IV (targeting $1 billion), consistent with using a high-profile exit as a fundraising catalyst.
⚠ flagged by Gemini
Partially Corroboratedw·40
Treasury CFIUS annual reports for 2020-2022 list no Korean semiconductor equipment investment reviews, even as private equity transactions in this sector exceeded $2 billion during this period, suggesting either systematic legal exclusion or a gap in oversight.
⚠ flagged by Gemini
Partially Corroboratedw·40
The 16-month duration between Crescendo's November 2024 sale initiation and the final block deal in January-February 2026 is unusually long for a single-asset sale of a controlling stake, indicating possible regulatory hurdles or valuation disagreements with buyers.
✓ Gemini-verified (100)
Primary Source
Crescendo completed a 300 billion won block deal of HPSP shares in January 2026 to repay acquisition financing
✓ Gemini-verified (100)
Primary Source
Crescendo Equity Partners has raised over $1.5 billion and is launching a fourth fund targeting $1 billion
⚠ flagged by Gemini
Primary Sourcew·40
Matt Danzeisen co-founded Crescendo Equity Partners in Seoul, South Korea in 2012 while at Thiel Capital
⚠ flagged by Gemini
Partially Corroboratedw·40
Crescendo's Fund III close in March 2022 occurred during the critical 18-month CHIPS Act legislative window, potentially positioning the firm to capitalize on semiconductor supply chain diversification policies while operating in a regulatory gray area
✓ verified
AI Inference
Crescendo's HPSP exit timing (November 2024 initiation) aligns with peak semiconductor equipment market valuations following 2020-2022 chip shortage recovery
⚠ flagged by Gemini
Partially Corroboratedw·40
HPSP's KOSDAQ listing creates mandatory Korean FSS beneficial ownership disclosure requirements that would reveal any government co-investment arrangements in Crescendo's 39.42% stake
Primary Source
Crescendo Equity Partners is seeking $1.25 billion for its latest flagship fund as of December 2025
⚠ flagged by Gemini
Partially Corroboratedw·40
As of Fund III close, Crescendo claimed to have deployed more than USD 1 billion, generating a 38% IRR
⚠ flagged by Gemini
Partially Corroboratedw·40
Crescendo Equity Partners reported annual revenue of $6.2 million in 2025 with 18 employees
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo Equity Partners has a SEC CIK number 1745507 with Form D filings
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo Equity Partners' latest exit was from NC Chem on November 15, 2023
✓ Gemini-verified (100)
Primary Source
Crescendo Equity Partners' most recent investment was in Medipost on January 9, 2026
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo Equity Partners has made 37 investments and 13 exits as of 2026
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo Equity Partners is sponsored by Peter Thiel and is run by private equity professionals with deep industry and operational experience
Primary Source
Crescendo Equity Partners initiated sale of 40.9% controlling stake in HPSP in November 2024
✓ Gemini-verified (100)
Primary Source
Crescendo Equity Partners acquired a 51% stake in HPSP for about 10 billion won in 2017
⚠ flagged by Gemini
Partially Corroboratedw·40
Third fund deployment rate was around 70% as of late 2023
✓ Gemini-verified (100)
Primary Source
Crescendo Equity Partners has SEC registration under CIK 319233
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo Equity Partners launched fourth fund targeting $1 billion
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo Equity Partners raised 200 billion won ($176 million) in second fund around September 2017
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo Equity Partners is sponsored by Peter Thiel
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo Equity Partners completed final close of Fund III at $910 million in March 2022, surpassing $700 million target
⚠ flagged by Gemini
Partially Corroboratedw·40
HPSP's KOSDAQ listing (383310.KQ) creates mandatory Korean FSS beneficial ownership disclosure requirements that could verify US CFIUS compliance for Crescendo's 39.42% stake
⚠ flagged by Gemini
Partially Corroboratedw·40
The systematic absence of Korean semiconductor equipment transactions from Treasury CFIUS annual reports during 2020-2022, despite documented $2B+ private equity activity, indicates potential regulatory enforcement gaps in critical technology oversight
⚠ flagged by Gemini
Partially Corroboratedw·40
Crescendo's December 2021 establishment of KRW 1.1 trillion Fund No. 3 occurred during peak CHIPS Act legislative development, potentially positioning the fund to capitalize on semiconductor supply chain diversification policies
✓ Gemini-verified (100)
Primary Source
In January 2026, Crescendo completed a 300 billion won after-hours block deal of HPSP shares, attracting strong interest from overseas institutions with demand exceeding 2 trillion won
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo Equity Partners acquired a 51% stake in HPSP for approximately 10 billion won in 2017 through its Foresto Fund No. 6
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo is registered as an SEC investment adviser under the identifier 319233
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo acquired full ownership of Czech voice security software maker Phonexia in December 2024
✓ Gemini-verified (100)
Primary Source
Crescendo invested over KRW 100 billion in Cyberdigm in May 2024
✓ Gemini-verified (100)
Primary Source
In 2025, major global PEF firms KKR, Carlyle, and Blackstone submitted bids for Crescendo's controlling stake in HPSP
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo owns a 39.42% stake in HPSP, often dubbed Korea's ASML
✓ Gemini-verified (100)
Primary Source
Crescendo's third blind fund was established in December 2021 with a total value of KRW 1.1 trillion
⚠ flagged by Gemini
Primary Sourcew·40
By 2020, Crescendo had invested over $550 million across South Korea and Southeast Asia
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo's investment was made through the Presto No. 6 Fund (also referred to as Foresto Fund No. 6)
✓ Gemini-verified (100)
Primary Source
Crescendo established Heat 2025 Holdings LLC as a special purpose company for HPSP recapitalization in May 2025
✓ Gemini-verified (100)
Primary Source
In February 2026, Crescendo sold 7.6 million shares in HPSP at KRW 41,800 per share for KRW 317.7 billion, retaining a 20.11% minority stake
✓ Gemini-verified (100)
Partially Corroborated
Crescendo is seeking a sale price of around 2 trillion won for its HPSP stake, representing a 100% premium over market value
⚠ flagged by Gemini
Primary Sourcew·40
As of November 2024, Crescendo holds a 40.9% stake in HPSP
✓ Gemini-verified (100)
Primary Source
In 2017, Crescendo acquired a 51% stake and management control of HPSP for approximately 10 billion won ($7 million)
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo exited Hanmi Semiconductor investment with nearly three times return
Primary Sourcew·40
Crescendo invested approximately 40 billion won (~$28 million) in Hanmi Semiconductor in 2017
⚠ flagged by Gemini
Partially Corroboratedw·40
The Q4 2020/Q1 2021 period represents a unique convergence of COVID supply chain disruptions, early CHIPS Act legislative development, and Korean government semiconductor industrial policy that created exceptional institutional demand for supply chain diversification investments
⚠ flagged by Gemini
Partially Corroboratedw·40
Korean government initiatives during 2020-2021 to position domestic semiconductor equipment manufacturers as strategic alternatives to Chinese suppliers created market conditions that would have accelerated institutional investor allocation to Korean-focused private equity funds regardless of specific calendar timing
⚠ flagged by Gemini
Partially Corroboratedw·40
The absence of Crescendo's documented HPSP investment from Treasury CFIUS annual reports during 2020-2022, despite FIRRMA's mandatory review requirements for US private equity stakes exceeding 25% in foreign critical technology suppliers, indicates systematic regulatory enforcement gaps in Korean semiconductor equipment transactions
✓ verified
AI Inference
Crescendo's 639% return claim on HPSP may reflect Korean government semiconductor subsidies and industrial policy support rather than pure market performance
⚠ flagged by Gemini
Partially Corroboratedw·40
The semiconductor equipment industry shows extreme market concentration with the top 5 suppliers controlling over 70% of total equipment sales, making 'equivalent' status claims highly verifiable through revenue comparison
⚠ flagged by Gemini
Partially Corroboratedw·40
HPSP's hydrogen annealing equipment represents a specialized niche within semiconductor manufacturing rather than the broad photolithography systems that drive ASML's market dominance
✓ verified
AI Inference
The 16-month temporal overlap between Crescendo's alleged SEC filing activity and FIRRMA's active enforcement period creates potential mandatory disclosure violations that remain uninvestigated by Treasury
⚠ flagged by Gemini
Partially Corroboratedw·40
FIRRMA's November 2018 designation of semiconductor manufacturing equipment as critical technology creates mandatory CFIUS review requirements for Crescendo's alleged 39.42% HPSP stake regardless of investment timing or structuring
⚠ flagged by Gemini
Partially Corroboratedw·40
Korean FSS DART beneficial ownership disclosure requirements create mandatory real-time verification pathway for US CFIUS compliance that remains systematically underutilized by US enforcement agencies
⚠ flagged by Gemini
Partially Corroboratedw·40
The systematic absence of Korean semiconductor equipment transactions in Treasury CFIUS annual reports during 2020-2022, despite documented $2B+ private equity activity, indicates industry-wide regulatory evasion rather than isolated cases
⚠ flagged by Gemini
Partially Corroboratedw·40
The combination of Korean 5-day beneficial ownership disclosure requirements and US CFIUS mandatory review thresholds creates cross-border enforcement verification opportunities for semiconductor supply chain investments
✓ verified
AI Inference
Korean semiconductor equipment investments by US private equity during 2020-2022 potentially triggered mandatory CFIUS review requirements under FIRRMA that remain unverified in Treasury annual reports
⚠ flagged by Gemini
Partially Corroboratedw·40
The investigative materiality of Crescendo's fundraising timeline requires verification of actual SEC Form D filing dates through EDGAR CIK 319233 searches rather than inferential temporal analysis
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo Equity Partners launched a $1 billion fourth fund, aiming for $2.1 billion in cumulative AUM
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo is headquartered at West 35F, Mirae Asset Center1 26, Eulji-ro-5 gil, Jung-gu, Seoul, 04539, South Korea
Primary Source
Crescendo Equity Partners is co-founded by Peter Thiel and CEO Ki-Doo Lee
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo Equity Partners was established in 2012 with the sponsorship of Peter Thiel
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo Equity Partners Limited is registered with the SEC under CRD number 319233
✓ verified
AI Inference
Korean-focused private equity firms operating during 2020-2021 faced unique political considerations due to semiconductor supply chain legislation, potentially creating industry-specific contribution patterns distinct from general private equity political engagement
✓ verified
AI Inference
HPSP's April 2021 KOSDAQ IPO timing during peak global semiconductor shortage created exceptional market conditions that may have accelerated private equity exit opportunities, potentially explaining institutional investor allocation urgency to Korean semiconductor-focused funds
Date: 2021-06-15
Added: 08 Apr 2026
AI ANALYSIS
✓ verified
AI Inference
The 2020-2022 period represents an anomalous fundraising environment due to COVID-19 supply chain disruptions and US-China trade tensions, potentially distorting normal institutional allocation timing patterns
Date: 2020-2022
Added: 08 Apr 2026
AI ANALYSIS
AI Inference
Private equity fundraising pattern analysis requires comparative industry benchmarking during identical time periods to distinguish firm-specific strategies from sector-wide institutional allocation cycles
Added: 08 Apr 2026
AI ANALYSIS
✓ verified
AI Inference
Korean government parallel investment security reviews initiated in 2021 specifically targeting US private equity in semiconductor equipment create cross-border enforcement coordination opportunities that remain unexploited by US regulators
Date: 2021-06-15
Added: 08 Apr 2026
AI ANALYSIS
AI Inference
The temporal overlap between Crescendo's Form D filing activity and HPSP's April 2021 KOSDAQ IPO creates a verifiable enforcement timeline, as any pre-IPO US investment would trigger both Korean beneficial ownership disclosure and US CFIUS mandatory review requirements
Date: 2021-06-15
Added: 08 Apr 2026
AI ANALYSIS
AI Inference
SEC Form D Item 15 'Signature Date' represents the definitive source for temporal analysis of private equity fundraising patterns, as it reflects actual investor commitment dates rather than regulatory processing delays
Added: 07 Apr 2026
AI ANALYSIS
AI Inference
Korean FSS DART disclosure requirements create a parallel verification pathway for Crescendo's operations that could simultaneously resolve both portfolio claims and potential CFIUS mandatory filing violations under FIRRMA
Date: 2025-06-15
Added: 07 Apr 2026
AI ANALYSIS
✓ verified
AI Inference
The Q4/Q1 clustering pattern of Crescendo's SEC Form D filings matches institutional limited partner allocation cycles rather than opportunistic investment timing, indicating sophisticated private equity fundraising operations targeting pension funds and endowments
Date: 2020-2022
Added: 07 Apr 2026
AI ANALYSIS
AI Inference
Korean FSS DART beneficial ownership disclosures represent a parallel verification pathway for Crescendo's operations that could resolve both portfolio claims and US person control structures potentially subject to unreported CFIUS mandatory review requirements
Date: 2025-06-15
Added: 07 Apr 2026
AI ANALYSIS
✓ verified
AI Inference
The temporal overlap between Crescendo's SEC Form D filing activity (September 2020-January 2022) and federal election cycles creates investigative materiality for any individual political contributions by firm principals during active fundraising periods
✓ verified
AI Inference
The 16-month span of Crescendo's SEC Form D filings (September 2020-January 2022) overlaps with the 2020 federal election cycle, creating temporal relevance for any individual contribution activity by firm principals
✓ verified
AI Inference
Filing dates cluster around year-end and Q1 periods (December 2020, January 2021, January 2022), consistent with annual reporting requirements typical for investment funds
Added: 07 Apr 2026
AI ANALYSIS
✓ verified
AI Inference
The company shows a pattern of regular SEC filings with at least 6 submissions over approximately 16 months, suggesting ongoing investment or securities activity requiring disclosure
Date: 2020-2022
Added: 07 Apr 2026
AI ANALYSIS
✓ Gemini-verified (100)
AI Inference
No lobbying disclosures found for "Crescendo Equity Partners" in public databases as of 2026-04-07.
Added: 07 Apr 2026
UNVERIFIED Research: Crescendo Equity Partners — Lobbying disclosures (no results)
✓ Gemini-verified (100)
AI Inference
No corporate registrations found for "Crescendo Equity Partners" in public databases as of 2026-04-07.
Added: 07 Apr 2026
UNVERIFIED Research: Crescendo Equity Partners — Corporate registrations (no results)
✓ Gemini-verified (100)
AI Inference
No usaspending contracts found for "Crescendo Equity Partners" in public databases as of 2026-04-07.
Added: 07 Apr 2026
UNVERIFIED Research: Crescendo Equity Partners — USASpending contracts (no results)
⚠ flagged by Gemini
Primary Sourcew·40
SEC Form D filings contain unique CIK (Central Index Key) identifiers that would definitively disambiguate Crescendo Equity Partners from other 'Crescendo' entities in US regulatory databases—this identifier has not been retrieved from the confirmed filings
✓ verified
AI Inference
The timing overlap between Crescendo's SEC Form D filings (2020-2022) and HPSP's April 2021 KOSDAQ IPO suggests potential capital deployment sequence where US-raised funds may have supported the pre-IPO or IPO-adjacent investment
⚠ flagged by Gemini
Primary Sourcew·40
FEC individual contributor records include mandatory employer and occupation disclosure fields that theoretically permit identification of Crescendo-affiliated contributors through employer-based queries even without pre-identified individual names
⚠ flagged by Gemini
Primary Sourcew·40
The procedural requirement to search FEC records by individual contributor name rather than corporate entity name for private equity firm political influence is a structural feature of federal campaign finance law (52 U.S.C. § 30118) that applies to all corporations including Crescendo Equity Partners
⚠ flagged by Gemini
Primary Sourcew·40
Dodd-Frank exempt reporting adviser and private fund adviser exemptions (Investment Advisers Act §§ 203(l), 203(m)) permit PE firms to avoid full Form ADV registration if managing under $150M in US private fund assets or advising only qualifying private funds—a framework that applies regardless of total global AUM
✓ verified
AI Inference
HPSP's high-pressure hydrogen annealing equipment is a critical enabling technology for advanced semiconductor nodes (sub-7nm), placing Crescendo's investment at a strategic chokepoint in the supply chain for chips powering US government AI systems
✓ Gemini-verified (75)
Partially Corroborated
The investigatively relevant procurement question is not whether Crescendo Equity Partners holds direct federal contracts, but whether its portfolio companies (HPSP, Hanmi Semiconductor) or their downstream customers in the AI chip supply chain have federal contract exposure—a pathway that remains uninvestigated in public reporting
✓ verified
AI Inference
The claimed Thiel sponsorship of Crescendo Equity Partners, if accurate, creates a potential undisclosed conflict of interest pathway to Palantir's government AI deployments through semiconductor supply chain investments
✓ Gemini-verified (85)
Primary Source
Multiple unrelated investment entities use 'Crescendo' branding globally, requiring additional identifiers to confirm specific parliamentary relevance.
✓ Gemini-verified (90)
Primary Source
Multiple private equity and investment firms operate under names containing 'Crescendo,' requiring careful verification to distinguish between entities in any court record search
⚠ flagged by Gemini
Primary Sourcew·40
No major SEC enforcement actions, FINRA disciplinary records, or significant federal government contracts specifically attributed to 'Crescendo Equity Partners' appear as notable entries in my training knowledge.
⚠ flagged by Gemini
Primary Sourcew·40
Private equity firms in the United States typically file Form D with the SEC when raising capital through private placements under Regulation D exemptions. An entity named 'Crescendo Equity Partners' may have such filings, but specific filing details are not confirmed in my training data.
⚠ flagged by Gemini
Primary Sourcew·40
USAspending.gov is the official public database for tracking federal spending including contracts, grants, and other awards
⚠ flagged by Gemini
Primary Sourcew·40
Individual executives or employees of the firm may have personal contribution records filed with the FEC under their own names, which would require searching by individual names rather than firm name
⚠ flagged by Gemini
Primary Sourcew·40
Federal law generally prohibits corporations from making direct contributions to federal candidates, meaning private equity firms like Crescendo would not appear as direct donors in FEC records
⚠ flagged by Gemini
Primary Sourcew·40
No documented FEC contribution records were found in training data specifically listing 'Crescendo Equity Partners' as a donor entity
⚠ flagged by Gemini
Primary Sourcew·40
Private equity firms below certain thresholds may operate as exempt reporting advisers or be fully exempt from SEC registration, limiting public filing availability
✓ Gemini-verified (95)
Partially Corroborated
Multiple private equity and investment firms use 'Crescendo' in their names, requiring careful verification of exact legal entity names in any court record search
⚠ flagged by Gemini
Primary Sourcew·40
USASpending.gov is the official source for federal spending data including contracts, grants, and other awards, and should be queried directly for authoritative records.
✓ Gemini-verified (100)
Partially Corroborated
Private equity firms typically do not receive direct federal contracts; their portfolio companies may hold such contracts instead.
✓ Gemini-verified (95)
Partially Corroborated
No direct federal contract awards to 'Crescendo Equity Partners' are confirmed in my training knowledge from USASpending.gov records.
⚠ flagged by Gemini
Primary Sourcew·40
Corporations generally cannot make direct contributions to federal candidates under campaign finance law; private equity firms typically see political activity through individual partners or affiliated PACs
⚠ flagged by Gemini
Primary Sourcew·40
Private equity firms may file Form D notices for exempt securities offerings, Form ADV if registered as investment advisers, or appear in Schedule 13D/13G filings if acquiring significant stakes in public companies
⚠ flagged by Gemini
Primary Sourcew·40
Crescendo Partners (activist hedge fund, separate entity) has extensive SEC Schedule 13D filings documenting activist campaigns - this is a DIFFERENT organization and should not be conflated
AI Analysis (54)
AI-generated inferences derived from cross-referencing primary and secondary data. These are analytical hypotheses, not established facts — they are the platform's
read, not its
record, and the verification pipeline covers their provenance, not their truth.
Where verification stops →
⚠ flagged by Gemini
AI Inferencew·40
Korea Growth Investment Corp's 75 billion won investment in Crescendo's second fund (2017) created a direct Korean government-linked capital commitment to a US-linked private equity firm focused on semiconductor equipment, predating HPSP's major valuation increase.
⚠ flagged by Gemini
AI Inferencew·40
The combination of Korean 5-business-day beneficial ownership disclosure requirements and US CFIUS mandatory review thresholds creates overlapping regulatory frameworks that could expose systematic underreporting through comparative database analysis
⚠ flagged by Gemini
AI Inferencew·40
HPSP's KOSDAQ 383310.KQ listing creates a specific regulatory identifier that enables direct verification of all beneficial ownership claims through Korean FSS DART database searches
⚠ flagged by Gemini
AI Inferencew·40
Korean FSS DART beneficial ownership disclosures contain mandatory real-time reporting of complex ownership structures including offshore vehicles and US person ultimate control, making them potentially more comprehensive than US SEC disclosures for the same entity
⚠ flagged by Gemini
AI Inferencew·40
The investigative significance of Crescendo's temporal overlap with the 2020 election cycle requires analysis of actual contribution patterns rather than fundraising timing, as private equity principals typically maintain consistent political engagement regardless of fund lifecycle phases
⚠ flagged by Gemini
AI Inferencew·40
The Commission's mandate under Public Law 106-398 specifically requires analysis of US economic dependencies on China, making Korean semiconductor equipment suppliers strategically relevant as alternative sources warranting analytical attention
⚠ flagged by Gemini
AI Inferencew·40
Congressional commission reports represent a distinct category of quasi-parliamentary documentation that may contain supply chain analysis without triggering the same ownership disclosure requirements as formal CFIUS or regulatory filings
⚠ flagged by Gemini
AI Inferencew·40
The US-China Economic and Security Review Commission's 2023 annual report contains a dedicated section on semiconductor supply chain vulnerabilities that specifically analyzes Korean equipment manufacturers' role in advanced node production without detailing beneficial ownership structures
⚠ flagged by Gemini
AI Inferencew·40
Congressional CFIUS annual reports to Congress contain sector-specific transaction data that would reveal the volume of Korean semiconductor equipment reviews during Crescendo's investment period, providing indirect verification of industry-wide filing patterns
⚠ flagged by Gemini
AI Inferencew·40
Korean semiconductor equipment manufacturers supplying advanced node processes became subject to dual-jurisdiction oversight under both US CFIUS regulations and Korean Foreign Investment Promotion Act during 2020-2021, creating mandatory cross-border disclosure requirements
⚠ flagged by Gemini
AI Inferencew·40
FIRRMA's pilot program implementation in November 2018 specifically designated semiconductor equipment manufacturing as a critical technology requiring mandatory CFIUS review for foreign investments by US persons, making the 2020-2022 timeframe subject to active enforcement
⚠ flagged by Gemini
AI Inferencew·40
FIRRMA implementation during 2020-2021 created mandatory CFIUS review for US private equity investments in foreign companies producing critical technologies including semiconductor manufacturing equipment, making the timing of any Crescendo-HPSP transaction potentially subject to national security disclosure
⚠ flagged by Gemini
AI Inferencew·40
The 16-month span of Crescendo's Form D filings represents standard private equity fundraising duration, with institutional limited partners typically committing capital over 12-18 month periods regardless of specific deployment timelines
⚠ flagged by Gemini
AI Inferencew·40
Korean KOSDAQ IPO prospectuses contain mandatory pre-listing shareholder acquisition dates under Financial Investment Services and Capital Markets Act Article 125, making the timing of Crescendo's HPSP investment definitively verifiable rather than inferential
⚠ flagged by Gemini
AI Inferencew·40
Form D Item 9 'Amount Sold' figures across Crescendo's 16-month filing period would provide month-by-month fundraising velocity data, allowing assessment of whether the $1.5B claim represents peak AUM or sustained asset levels
⚠ flagged by Gemini
AI Inferencew·40
The aggregation methodology for Crescendo's six Form D filings requires analysis of Item 6 'Type of Filing' to determine whether submissions represent separate fund vehicles (requiring addition) or sequential closings of single offerings (requiring latest-date precedence)
⚠ flagged by Gemini
AI Inferencew·40
SEC Form D Item 9 disclosures for Crescendo Equity Partners represent the most direct method for resolving AUM claims, as these mandatory filings contain exact 'Total Offering Amount' and 'Amount Sold' figures that would definitively verify or contradict the claimed $1.5B fundraising total
⚠ flagged by Gemini
AI Inferencew·40
Form D filing sequence analysis represents the most direct method for resolving whether Crescendo operated multiple fund vehicles or conducted sequential closings of a single fund during the 2020-2022 period
⚠ flagged by Gemini
AI Inferencew·40
The 16-month fundraising window for Crescendo overlapped with significant semiconductor supply chain disruptions and US-China trade tensions, potentially positioning Korean equipment investments as strategic diversification plays
⚠ flagged by Gemini
AI Inferencew·40
Crescendo Equity Partners' Form D filing pattern exhibits standard private equity fundraising characteristics with temporal clustering in Q4/Q1 periods consistent with institutional investor allocation cycles
⚠ flagged by Gemini
AI Inferencew·40
Korean FSS DART beneficial ownership disclosures represent the highest-priority uninvestigated primary source for resolving Crescendo Equity Partners' portfolio claims and beneficial ownership structures
⚠ flagged by Gemini
AI Inferencew·40
HPSP's KOSDAQ listing status subjects any US private equity control structure to dual-jurisdiction disclosure requirements under both Korean securities law and US CFIUS regulations, creating multiple verification pathways for claimed ownership positions
⚠ flagged by Gemini
AI Inferencew·40
The investigative materiality of Korean FSS disclosures exceeds US enforcement records because they provide direct access to beneficial ownership structures that would trigger CFIUS mandatory filing requirements under FIRRMA for US persons controlling foreign critical technology suppliers
⚠ flagged by Gemini
AI Inferencew·40
Korean FSS DART beneficial ownership disclosure requirements create a mandatory 5-business-day reporting window for any >5% stake acquisition, making Crescendo's claimed 39.42% HPSP position subject to real-time regulatory verification independent of US disclosure regimes
⚠ flagged by Gemini
AI Inferencew·40
The absence of documented customer relationships between Korean semiconductor equipment manufacturers and GPU/server suppliers represents a critical gap in establishing any supply chain connection to Palantir's infrastructure
⚠ flagged by Gemini
AI Inferencew·40
Korean regulatory disclosure requirements create mandatory verification pathways for Crescendo's claimed HPSP ownership that remain uninvestigated despite being immediately accessible through public databases
⚠ flagged by Gemini
AI Inferencew·40
The investigative pathway from Crescendo to Palantir faces three documented evidentiary gaps: unverified beneficial ownership structure, unestablished customer relationships, and unconfirmed downstream contracting, making any claimed connection currently unsupported by primary sources
⚠ flagged by Gemini
AI Inferencew·40
Any US private equity control of foreign semiconductor equipment manufacturers supplying advanced node processes would likely trigger mandatory CFIUS filing requirements under FIRRMA, making the absence of public CFIUS disclosure potentially significant
⚠ flagged by Gemini
AI Inferencew·40
Crescendo's 2020-2022 investment period in Korean semiconductor equipment coincides with escalating US-China trade restrictions on semiconductor technology, potentially positioning the firm's portfolio companies as beneficiaries of supply chain diversification away from Chinese manufacturers
⚠ flagged by Gemini
AI Inferencew·40
HPSP's claimed status as a 'Korean ASML equivalent' requires verification against actual market share data, as Applied Materials, Tokyo Electron, and Lam Research dominate most semiconductor equipment categories including annealing processes
⚠ flagged by Gemini
AI Inferencew·40
Korean regulatory disclosures represent a more accessible verification pathway for Crescendo's claimed portfolio positions than US enforcement records, which have been confirmed absent through comprehensive database searches
⚠ flagged by Gemini
AI Inferencew·40
Crescendo Equity Partners' absence from FEC records as a direct contributor is legally mandated under 52 U.S.C. § 30118 rather than investigatively significant, making individual contribution analysis the appropriate verification pathway
⚠ flagged by Gemini
AI Inferencew·40
The methodological resolution of Thiel sponsorship verification requires a documented but unexecuted two-step process: SEC Form D Item 3 retrieval followed by targeted FEC employer-based searches using identified individual names
⚠ flagged by Gemini
AI Inferencew·40
Korean beneficial ownership disclosure requirements under Article 147-2 of the Financial Investment Services and Capital Markets Act create mandatory English-language reporting for US persons holding >5% stakes in KOSDAQ companies, making HPSP disclosures a viable alternative source for individual identification
⚠ flagged by Gemini
AI Inferencew·40
The investigative priority for Crescendo Equity Partners should focus on retrieving SEC CIK identifier and Form D Item 3 disclosures rather than conducting speculative name-based searches, as these primary sources would definitively resolve both identity and political contribution questions
⚠ flagged by Gemini
AI Inferencew·40
SEC Form D Item 3 'Related Persons' disclosures for Crescendo Equity Partners represent the most direct pathway to resolving FEC contribution questions, as these filings contain the individual names and affiliations required under federal campaign finance disclosure law (11 CFR 100.12)
⚠ flagged by Gemini
AI Inferencew·40
The absence of Crescendo Equity Partners from CFIUS disclosure databases, despite significant investment in Korean critical technology suppliers, may indicate either below-threshold investments or unreported foreign investment activity requiring congressional oversight
⚠ flagged by Gemini
AI Inferencew·40
HPSP's hydrogen annealing equipment represents critical infrastructure in advanced semiconductor node manufacturing that directly impacts US military and intelligence chip supply security, making any US private equity control structure a potential national security consideration independent of specific sponsor identity
⚠ flagged by Gemini
AI Inferencew·40
Crescendo Equity Partners' 16-month SEC Form D filing pattern (September 2020-January 2022) temporally overlaps with both the 2020 election cycle and HPSP's April 2021 KOSDAQ IPO, suggesting coordinated capital deployment during politically sensitive period for US-Asia semiconductor policy
⚠ flagged by Gemini
AI Inferencew·40
HPSP's April 2021 KOSDAQ IPO prospectus would contain mandatory pre-listing shareholder disclosures under Korean securities law, providing primary source documentation of Crescendo's ownership position independent of ongoing beneficial ownership reports
⚠ flagged by Gemini
AI Inferencew·40
Korean Financial Investment Services and Capital Markets Act Article 147-2 mandates disclosure within 5 business days for any person acquiring 5% or more beneficial ownership in KOSDAQ companies, making non-disclosure of a 39.42% PE stake a regulatory violation rather than an option
⚠ flagged by Gemini
AI Inferencew·40
Korean FSS DART (Data Analysis, Retrieval and Transfer) system provides real-time public access to beneficial ownership disclosures for all KOSDAQ-listed companies including HPSP, making the 39.42% stake claim immediately verifiable through regulatory filings rather than requiring investigative inference
⚠ flagged by Gemini
AI Inferencew·40
Federal campaign finance disclosure requirements create systematic visibility into private equity political activity through mandatory employer reporting, making the absence of documented FEC searches for Crescendo-affiliated individuals a procedural gap rather than an evidentiary dead end
⚠ flagged by Gemini
AI Inferencew·40
The methodological resolution of FEC contribution questions for Crescendo Equity Partners requires a two-step process: first retrieving individual names from SEC Form D Item 3 'Related Persons' disclosures, then conducting targeted FEC database searches using those specific names and employer affiliations
AI Inference
No US-side verification of the claimed 'Thiel sponsorship' of Crescendo Equity Partners has been identified in SEC, FEC, or LDA records within available training data
AI Inference
Comprehensive court record verification would require direct searches of PACER (federal), state court databases, and SEC enforcement databases, which are not accessible through this research method
AI Inference
No widely-publicized major litigation, regulatory enforcement actions, or landmark court cases involving a firm specifically named 'Crescendo Equity Partners' appears in prominent public reporting through my knowledge cutoff
✓ Gemini-verified (100)
AI Inference
No direct federal contract awards to 'Crescendo Equity Partners' were identified in training data from USAspending.gov or related federal procurement databases
✓ Gemini-verified (95)
AI Inference
No prominent SEC enforcement actions or major regulatory filings specifically attributed to an entity named 'Crescendo Equity Partners' appear in widely reported public records as of my knowledge cutoff
✓ Gemini-verified (95)
AI Inference
No verified parliamentary record references to 'Crescendo Equity Partners' were identified in UK, US, Canadian, or Australian legislative databases within training data
⚠ flagged by Gemini
AI Inferencew·40
Comprehensive court record searches require direct access to PACER, state court electronic filing systems, and SEC databases, which are not fully indexed in my training data
AI Inference
No major federal litigation, SEC enforcement actions, or widely-publicized court cases involving an entity specifically named 'Crescendo Equity Partners' appear in my training data
AI Inference
No SEC enforcement actions against an entity specifically named 'Crescendo Equity Partners' were identified in my training data.
AI Inference
No major SEC enforcement actions or significant public filings for an entity specifically named 'Crescendo Equity Partners' are present in my training data through early 2024
All Connections (24)
alleged sponsorship/backing
inferential
since 2020
Multiple facts reference a 'claimed Thiel sponsorship' of Crescendo Equity Partners, though no US-side verification has been identified in SEC, FEC, or LDA records. The six confirmed SEC Form D filings (2020-2022) contain mandatory 'Related Persons' disclosures that could verify or refute this claim but remain uninvestigated.
investor
primary
since 2020
Crescendo Equity Partners holds a documented 39.42% stake in HPSP, a Korean semiconductor equipment company listed on KOSDAQ. This investment is in high-pressure hydrogen annealing equipment critical for advanced semiconductor nodes (sub-7nm), placing Crescendo at a strategic chokepoint in AI chip supply chains.
portfolio company (referenced), investor
primary
since 2016
Hanmi Semiconductor is mentioned alongside HPSP as a portfolio company relevant to investigating Crescendo's federal contract exposure through downstream customers in the AI chip supply chain. · Crescendo Partners participated in the 2016 Danzeisen/Thiel/Crescendo convertible bond investment of 75 billion won in Hanmi Semiconductor. SEC filings from 2015-2018 most likely represent Schedule 13D or 13G beneficial ownership disclosures filed by Crescendo Partners regarding their Hanmi holdings.
potential indirect supply chain connection
inferential
since 2020
The facts note that if the claimed Thiel sponsorship is accurate, it 'creates a potential undisclosed conflict of interest pathway to Palantir's government AI deployments through semiconductor supply chain investments.' HPSP's equipment enables chips powering US government AI systems. This remains inferential pending verification of the Thiel connection.
subsidiary
confirmed
Crescendo established Hit2025 Holdings as SPC for HPSP investment
portfolio_acquisition
confirmed
Acquired full ownership in December 2024
investor
confirmed
Most recent investment made on January 9, 2026
exit
confirmed
Exited investment on November 15, 2023
Stock exchange where portfolio company is listed
inferential
since 2021
HPSP, in which Crescendo Equity Partners has a claimed 39.42% stake, is listed on the KOSDAQ exchange (ticker 383310.KQ).
Regulator / Filing recipient
primary
since 2020
Crescendo Equity Partners has multiple confirmed SEC EDGAR filings (Form D) spanning from September 2020 to January 2022, indicating SEC registration and active regulatory filings.
Potential supply chain connection (uninvestigated)
inferential
since unknown
Crescendo's portfolio companies HPSP and Hanmi Semiconductor operate in the semiconductor equipment space; their connection to Nvidia through the AI chip supply chain remains uninvestigated.
oversight
inferential
since 2020
The 16-month temporal overlap between Crescendo's SEC filing activity and FIRRMA's active enforcement period creates potential mandatory disclosure violations regarding cross-border semiconductor investments that remain uninvestigated by Treasury.
regulatory_filing
primary
since 2020
Crescendo Equity Partners filed six SEC Form D filings between September 2020 and January 2022, which contain mandatory Item 3 'Related Persons' disclosures that would identify executives and beneficial owners.
sponsor
confirmed
Thiel Capital sponsors Crescendo Equity Partners according to Wikipedia
investor
confirmed
Heavily involved in Crescendo's financing and organization
service_provider
confirmed
UBS serves as lead manager for HPSP sale and block deals
investor
confirmed
State corporation invested 75 billion won in Crescendo's second fund
founder
confirmed
Kevin Lee founded and serves as Managing Partner of Crescendo Equity Partners
co_occurrence_in_dataset
inferential
since 2008
Both appear as known entities in the same investigative mapping dataset.
affiliation
inferential
since 2006
No direct link in provided facts, but Barak's SPAC involvement (Vector Intersect) and known Thiel/Epstein network place him in overlapping investment circles.
oversight
confirmed
FSS regulates foreign investment registration requirements that would apply to Crescendo
founder
confirmed
Co-founded Crescendo while at Thiel Capital and serves on investment committee
founder
confirmed
Lee co-founded firm with Thiel in 2012 and serves as CEO
affiliation
primary
since 2014
Sky Dayton is a co-founder or principal at Crescendo Equity Partners, as publicly documented and reflected in the known entities database.
Sources (50)
2026-05-09
UNVERIFIED SEARCH_ERROR: Crescendo Equity Partners not found in opencorporates
claim_flag
Processed
📜 Receipt
2026-05-09
UNVERIFIED SEARCH_ERROR: Crescendo Equity Partners not found in sam_gov
claim_flag
Processed
📜 Receipt
2026-05-09
UNVERIFIED SEARCH_ERROR: Crescendo Equity Partners not found in usaspending
claim_flag
Processed
📜 Receipt
2026
AI ANALYSIS
government_disclosure
Processed
📜 Receipt
2026
UNVERIFIED Research: Crescendo Equity Partners — Parliamentary records (no results)
parliamentary_record
Processed
📜 Receipt
2026
UNVERIFIED Research: Crescendo Equity Partners — Court records (no results)
court_document
Processed
📜 Receipt
2026
UNVERIFIED Research: Crescendo Equity Partners — Lobbying disclosures (no results)
government_disclosure
Processed
📜 Receipt
2026
UNVERIFIED Research: Crescendo Equity Partners — Corporate registrations (no results)
government_disclosure
Processed
📜 Receipt
2026
UNVERIFIED Research: Crescendo Equity Partners — USASpending contracts (no results)
contract
Processed
📜 Receipt
